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The induction of mammalian cell proliferation requires the expression of a specific set of genes. Tumor promoters timulate cell growth by activating 
the Ca*+ and phospholipid-dependent protein kinase, protein kinase C (PKC). DNA topoisomerase I, a nuclear enzyme involved in transcription, 
was phosphorylated by activated PKC in vitro. Phosphorylation by PKC stimulated the DNA relaxation activity of topoisomerase I two- to three- 
fold. Therefore, DNA topoisomerase I is a substrate for PKC-mediated activation by phosphorylation and may serve as a nuclear target of mitogen- 
ic signals generated by tumor promoters in vivo. 
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1. INTRODUCTION 
The tumor-promoting phorbol ester TPA, and other 
mitogens, induce the expression of a set of genes in- 
volved in cellular growth and transformation. PKC, the 
serine and threonine-specific, Ca’+- and phospholipid- 
dependent, diacylglycerol-activated kinase, is the major 
receptor for TPA and is stimulated by treatment with 
ligands that induce the turnover of inositol phospho- 
lipids [l-3]. PKC is thought to regulate numerous 
metabolic events in the cell, including transmembrane 
signal transduction, gene expression and cell growth 
13341. 
Topoisomerase I transiently nicks a single DNA 
strand, catalyzing topological manipulations such as 
the relaxation of supercoiled DNA molecules [5-71. 
DNA topoisomerase I is required for rRNA synthesis 
[8-lo] and is associated with transcriptionally active 
genes [ 1 l-191, where it is probably involved in resolving 
local supercoiling caused by the transcriptional 
machinery [20-231. The activity of topoisomerase I in- 
creases during cell proliferation [24-261. 
Several in vitro substrates for PKC have been iden- 
tified, including the nuclear enzymes DNA topo- 
isomerase II [27,28], DNA methyltransferase [29], 
DNA polymerase a [30] and RNA polymerase II [3 l] as 
well as the nuclear factor CREB [32]. We report here 
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that PKC also phosphorylates DNA topoisomerase I in 
vitro resulting in a two- to three-fold increase in topo- 
isomerase I activity and suggest a role for nuclear PKC 
in the signal transduction pathway for the induction of 
cell proliferation. 
2. MATERIALS AND METHODS 
2.1. Enz_vmes 
Topoisomerase I was purified to near homogeneity from HeLa cells 
essentially as described previously [7]. PKC was purified from mouse 
brain using DES2 DEAE-cellulose (Whatman) and FPLC Mono Q 
(Pharmacia) column chromatography as described previously [33], 
except chromatography in the presence of ATP was not performed 
and the column buffers contained 0.1% Triton X-100. 
2.2. Phosphorylation reaction 
Reactions contained 20 mM Tris-HCl, pH 7.5, 1 mM MgClr, 
0.5 pg/ml leupeptin, 2 pg/ml aprotinin, 0.7 fig/ml pepstatin A, 
1 mM PMSF, 0.5 mM NasVO.+, 10 mM p-nitrophenyl phosphate, 
and either 0.1 mM CaClr, 25 pg/ml PS and 100 ng/ml TPA or 2 mM 
EGTA, in 30 ~1. Reactions were either in the presence or absence of 
0.016 units PKC (90 units/mg) and 25 ng topoisomerase I. One unit 
was defined as the amount of PKC required to transfer 1 nmol of “P, 
from [y-“P]ATP to histone (calf thymus, type III-S, Sigma) in 
15 min at 30°C. The reaction was initiated by adding 0.1 PM [Y-~*P]- 
ATP (22 pCi; ICN), incubated at 30°C for 15 min, and terminated by 
placing in an ice-water bath, adding 30~1 2 x Laemmli’s sample 
loading buffer [34] and heating in a boiling water bath for 5 min. 
Samples were electrophoresed on a 7% SDS-polyacrylamide gel for 
14 h at 70 V (4.6 V/cm). Gels were fixed, dried and exposed to 
Konica type A film with intensifying screens at - 70°C for 1 day. 
2.3. Immunoprecipitation 
The phosphorylation reaction (30 ~1) was terminated by placing in 
an ice-water bath and adding 2 ,ul 0.1 M EGTA, pH 7.5, and was then 
diluted with 1 ml 10 mM sodium phosphate, pH 7.5, 150 mM NaCl, 
0.5% Triton X-100, 1 mM EDTA, 0.5 mM NarV04, and 1 mM 
PMSF. This was added to 20 ~1 Protein A-Sepharose CL4B (Phar- 
macia) loaded with 6 pg anti-topoisomerase antibody [35] and in- 
cubated with gentle agitation at 4°C for 16 h. The supernatant (flow- 
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through) was collected by acid precipitation with 20% TCA and 
resuspended in 30~1 buffer A. The pellet (immunoprecipitate) was 
washed essentially as described previously [36] and resuspended in 
30 ~12 x Laemmli’s sample loading buffer [34]. Electropboresis was 
performed as described above. 
2.4. Topoisomerase I assay 
Topoisomerase 1 was phosphorylated by PKC essentially as 
described above, except he reaction was terminated by placing in an 
ice-water bath and adding 1.5 pl 0.1 M EGTA, pH 7.5. Reactions 
were diluted in 6% polyethylene glycol 8000, 20 mM Tris-HCl, pH 
7.5, 1 mM 2-mercaptoethanol, and 10 pg/ml bovine serum albumin. 
DNA relaxation activity was measured essentially as previously 
described [7,35]; the reaction was initiated by addition of diluted 
phosphorylation reaction (0.5 to 2.5 ng topoisomerase I). 
3. RESULTS 
Human DNA topoisomerase I was incubated with 
murine PKC in vitro to determine if phosphorylation 
mediated by PKC modulates topoisomerase I activity. 
Topoisomerase I was purified as a single polypeptide 
with a molecular mass of 100 000 Da (data not shown). 
PKC, a heterogeneous family of proteins with an 
average molecular mass of 77 000 Da, was activated by 
Ca2+ PS and TPA resulting in its autophosphorylation 
(fig.1: lane 2). The phosphorylation of PKC in the 
absence of the activators Ca2+, PS and TPA was less 
than 10% of the phosphorylation in their presence 
(fig.1, lane 1). 
The topoisomerase I preparation contained no auto- 
phosphorylating activity in the presence or absence of 
Ca2+, PS and TPA (fig.1, lanes 3,4). However, topo- 
isomerase I was significantly phosphorylated by ac- 
tivated PKC in vitro (fig.1, lane 6). The identity of the 
phosphorylated protein was confirmed by immuno- 
precipitation from the PKC reaction with an anti-topo- 
isomerase I antiserum [35] (fig.2). The possibility that 
one of the ten other phosphoproteins in the PKC frac- 
tion is a kinase that is activated by PKC and phos- 
phorylates topoisomerase I was eliminated by phos- 
phorylation of topoisomerase I by three distinct PKC 
subspecies isolated by fractionating the protein kinase 
preparation on hydroxyapatite column chromatogra- 
phy (Samuels, D.S. and Shimizu, N., manuscript in 
preparation). 
Phosphorylation of DNA topoisomerase I by PKC 
resulted in a two- to three-fold increase in topo- 
isomerase I activity as assayed by the conversion of 
supercoiled form I DNA molecules to their relaxed 
topoisomers. The relaxed form I topoisomers migrated 
slower than the supercoiled molecules during agarose 
gel electrophoresis due to their decreased compactness. 
The effect of PKC-mediated phosphorylation was 
tested after preincubation of topoisomerase I in the 
absence or presence of PKC in the phosphorylation 
reaction. 
Approximately 1.4 ng of untreated topoisomerase I 
relaxed half of the supercoiled plasmid while less than 
0.7 ng of topoisomerase I phosphorylated by PKC was 
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Fig. 1. Phosphorylation of DNA topoisomerase I by PKC. Reactions 
contained either Car&, PS and TPA (lanes 2,4,6) or EGTA (lanes 
1,3,5) and were in the presence (lanes 1,2,5,6) or absence (lanes 3,4) 
of PKC and the presence (lanes 3-6) or absence lanes 1,2) of DNA 
topoisomerase I (Topo I). 
Fig.2. Immunoprecipitation of phosphorylated DNA topoisomerase 
I. Immunoprecipitate using anti-DNA topoisomerase I antibody (lane 
1) and flow-through (lane 2) from the PKC phosphorylation reaction 
with DNA topoisomerase I (Top0 I). 
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Fig.3. Relaxation activity of phosphorylated DNA topoisomerase I. 
Reactions contained DNA topoisomerase I (0.5 to 2.5 ng) Prein- 
cubated in the phosphorylation reaction without PKC (Top0 I) or 
with PKC (Top0 I-PO:-). DNA topoisomerase I converted supercoil- 
ed form I plasmid DNA (I) to relaxed form I plasmid DNA which 
migrated through agarose gel electrophoresis at the same position as 
form II plasmid DNA (II). 
required to relax the same amount of DNA (fig.3). This 
trend persisted at other dilutions indicating that inhibi- 
tion of untreated topoisomerase I by ATP not expended 
in the reaction or PS and TPA not bound to PKC did 
not significantly contribute to the difference in activity 
of topoisomerase I preincubated with and without 
PKC. PKC had no intrinsic topoisomerase I activity 
(data not shown). 
4. DISCUSSION 
Topoisomerase I is most likely regulated in vivo by 
phosphorylation [37,38]. Its activity [24-261, but not 
the amount or stability of the protein [39], varies during 
the cell cycle. Topoisomerase I is isolated from 
Novikoff hepatoma cells and Xenopus laevis ovaries as 
a phosphoprotein and treatment of it with alkaline 
phosphatase decreases or abolishes its DNA relaxation 
activity [38,40]. In addition, it is phosphorylated by ca- 
sein kinase II in vitro resulting in the stimulation of its 
activity approximately three-fold [38,40,41]. 
DNA topoisomerase I is a nuclear enzyme; PKC has 
also been detected in the nucleus [42-521. Preliminary 
results indicate that a topoisomerase I-like phosphopro- 
tein is present in the nucleus of mouse fibroblasts from 
10 to 75 min after TPA treatment (Samuels, D.S. and 
Shimizu, N., unpublished results), shortly after the ap- 
pearance of activated PKC in the nucleus 
[42,45,46,49,52-591, when early genes required for 
DNA synthesis, such as c-&s and c-myc, are expressed. 
Topoisomerase I is likely to be a physiologically im- 
portant substrate for PKC because of its role in tran- 
scription and the effect phosphorylation has on its 
DNA relaxation activity. This post-translational regula- 
tion may be a key event in the induction of gene expres- 
sion by tumor promoters. Several other nuclear pro- 
teins are also substrates for PKC in vitro [27-321. 
Histones H2B, H4 and Hl’ [53,55], nuclear matrix pro- 
teins NP80 and NP33 [54], lamin B [56,57] as well as the 
nuclear proteins encoded by c-erbA [58] and ets-2 [59] 
are phosphorylated in response to TPA treatment in 
vivo. Thus, PKC could prove to be an essential kinase 
in the control of nuclear processes during, and in 
preparation for, cell growth and differentiation. 
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